Breastfeeding warning
Use during breastfeeding only on medical advice.
Leaflet DIPROPHOS 7mg / ml injection suspension
- Product code:
- W57960002
- Quantity:
- 1
- Indicated for:
- inflammatory dermatoses
- Route of administration:
- injectable
- Substance:
- betamethasone (glucocorticoid)
- ATC
- H02AB01 — Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids
Precautions:
Pregnancy warning
Use during pregnancy only on medical advice.
Betamethasone is a corticosteroid used to treat a wide range of inflammatory and allergic conditions. It is effective in reducing inflammation, itching, and redness associated with skin disorders such as dermatitis, psoriasis, and eczema. It is also used in the treatment of severe allergic reactions, rheumatic conditions, autoimmune diseases, and in some cases of adrenal insufficiency.
Betamethasone is available in various forms, including creams, ointments, injectable solutions, and tablets, with the choice depending on the type and severity of the condition. For topical use, it is applied to the affected area, usually once or twice daily, as directed by a doctor.
Side effects may include skin thinning, stretch marks, local irritation, or, in the case of systemic use, weight gain, high blood pressure, osteoporosis, and an increased risk of infections. Long-term or high-dose use should be closely monitored by a healthcare professional.
Betamethasone is contraindicated in untreated active infections, hypersensitivity to the active substance, and should be used with caution during pregnancy or breastfeeding. Patients must strictly follow their doctor’s recommendations to avoid adverse effects.
Betamethasone is available in various forms, including creams, ointments, injectable solutions, and tablets, with the choice depending on the type and severity of the condition. For topical use, it is applied to the affected area, usually once or twice daily, as directed by a doctor.
Side effects may include skin thinning, stretch marks, local irritation, or, in the case of systemic use, weight gain, high blood pressure, osteoporosis, and an increased risk of infections. Long-term or high-dose use should be closely monitored by a healthcare professional.
Betamethasone is contraindicated in untreated active infections, hypersensitivity to the active substance, and should be used with caution during pregnancy or breastfeeding. Patients must strictly follow their doctor’s recommendations to avoid adverse effects.
General data about DIPROPHOS 7mg / ml
- Substance:
- betamethasone
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W57960002
- Concentration:
- 7mg / ml
- Pharmaceutical form:
- injection suspension
- Packing volume:
- 1 ml
- Product type:
- Original
- Price:
- 23.24 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for betamethasone
Concentrations available for betamethasone
- 0.1%
- 0.5mg/g
- 1mg/g
- 1mg/ml
- 4mg/ml
- 7mg/ml
Combinations with other substances
- fusidic acid + betamethasone
- betamethasone + salicylic acid
- betamethasone + chloramphenicol
- betamethasone + clotrimazole
- betamethasone + clotrimazole + gentamicin
- betamethasone + gentamicin
- betamethasone + tetryzoline
- calcipotriol + betamethasone
- chloramphenicol + betamethasone
- gentamicin + betamethasone
- chlorpheniramine maleate + betamethasone
Compensation lists for DIPROPHOS 7mg / ml Merck Sharp & Dohme
B - Sublist B with 50% discount from the reference price
- Price
- 23.24 RON
- Copayment
- 11.62 RON
- Patient
- 11.62 RON
G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis
- Price
- 23.24 RON
- Copayment
- 23.24 RON
- Patient
- 0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
- Price
- 23.24 RON
- Copayment
- 23.24 RON
- Patient
- 0.00 RON